close
This ad will auto close in 10 seconds
Delhi High Court to resume hearing on petitions against Centre's ban on drugs

Delhi High Court to resume hearing on petitions against Centre's ban on drugs

Delhi High Court is likely to resume today the hearing on petitions by over 30 pharmaceutical majors, including Pfizer, Glenmark, Procter and Gamble (P&G) and Cipla, challenging the government's decision to ban sale of some of their fixed dose combination medicines.

Delhi HC allows DCGI to process Reliance's package insert of cancer drug

Delhi High Court today told the Drug Controller General of India (DCGI) that it can process the application of Reliance Life Sciences for approving the package insert of its breast cancer drug, the launch of which has been put on hold by a single judge of the court.

Govt initiates steps to promote clinical research in India

 The government has initiated a series of steps to fast-track approvals for clinical trials in India.

Do not support sabotage theory for Toansa plant: Ranbaxy

Rejecting sabotage theory at Toansa plant that faces USFDA ban, drug major Ranbaxy on Tuesday denied blaming the company's voluntary retirement scheme for the problem it faces.

DCGI asked to check quality of drugs sold by Ranbaxy: Govt

The government on Friday said it has ordered the Drug Controller General of India (DCGI) to check the quality of drugs produced by Ranbaxy Laboratories.